Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.
Weight-loss drugs
Posted inNPR
Dizzy after one drink? Social drinkers on obesity drugs lose the taste for alcohol
A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could be a promising new treatment for addiction.
Posted inNPR
Ozempic shows promise for treating alcohol and drug abuse, study finds
The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.
Posted inHealth, Stories
Thinking of buying Wegovy online. Here’s what to know about compounding pharmacies
As more people try weight-loss drugs like Wegovy, some skip the brand name and buy compounded semaglutide from online pharmacies. But some of these may not follow state and federal standards.
Posted inNPR
Have the new weight-loss drugs changed what it means to be body positive?
America is a land of contradictions; while we’re known as a nation that loves to eat, we also live within a culture that has long valued thinness as the utmost beauty standard.
Over the last several years the body positivity movement has pushed back on that notion. But then came a new class of weight-loss drugs.
New York Magazine contributing writer Samhita Mukhopadhyay grapples with the possible future of a movement like this in her recent article, So Was Body Positivity All A Big Lie?
She joins All Things Considered host Juana Summers to discuss the ever-evolving conversation on health, size, and whose business that is in the first place.
For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.
Email us at considerthis@npr.org.
